Education
About Us
Working with TipRanks
Follow Us
Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
INBP Stock Chart & Stats
$0.31
$0.02(5.88%)
At close: 4:00 PM EST
$0.31
$0.02(5.88%)
Day’s Range― - ―
52-Week Range$0.22 - $0.42
Previous CloseN/A
Volume200.00
Average Volume (3M)15.15K
Market Cap
$9.44M
Enterprise Value$5.14M
Total Cash (Recent Filing)$4.73M
Total Debt (Recent Filing)$761.00K
Price to Earnings (P/E)14.3
Beta0.09
Next Earnings
Feb 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding31,059,610
10 Day Avg. Volume31,065
30 Day Avg. Volume15,153
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.53
Price to Sales (P/S)0.20
P/FCF Ratio5.77
Enterprise Value/Market Cap0.54
Enterprise Value/Revenue0.13
Enterprise Value/Gross Profit0.99
Enterprise Value/Ebitda1.75
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Integrated BioPharma News
INBP FAQ
What was Integrated BioPharma Inc’s price range in the past 12 months?
Integrated BioPharma Inc lowest stock price was $0.22 and its highest was $0.42 in the past 12 months.
What is Integrated BioPharma Inc’s market cap?
Integrated BioPharma Inc’s market cap is $9.44M.
When is Integrated BioPharma Inc’s upcoming earnings report date?
Integrated BioPharma Inc’s upcoming earnings report date is Feb 18, 2026 which is in 68 days.
How were Integrated BioPharma Inc’s earnings last quarter?
Integrated BioPharma Inc released its earnings results on Nov 10, 2025. The company reported $0.004 earnings per share for the quarter, beating the consensus estimate of N/A by $0.004.
Is Integrated BioPharma Inc overvalued?
According to Wall Street analysts Integrated BioPharma Inc’s price is currently Overvalued.
Does Integrated BioPharma Inc pay dividends?
Integrated BioPharma Inc does not currently pay dividends.
What is Integrated BioPharma Inc’s EPS estimate?
Integrated BioPharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Integrated BioPharma Inc have?
Integrated BioPharma Inc has 31,059,610 shares outstanding.
What happened to Integrated BioPharma Inc’s price movement after its last earnings report?
Integrated BioPharma Inc reported an EPS of $0.004 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.452%.
Which hedge fund is a major shareholder of Integrated BioPharma Inc?
Currently, no hedge funds are holding shares in INBP
Company Description
Integrated BioPharma Inc
Integrated BioPharma (INBP) is a biopharmaceutical company focused on the development, manufacturing, and commercialization of innovative healthcare products. The company operates primarily in the pharmaceutical and nutraceutical sectors, offering a diverse portfolio of prescription and over-the-counter medications, dietary supplements, and wellness products. INBP is committed to advancing health through research and development, with a strong emphasis on delivering high-quality, effective solutions for various health conditions.
Technical Analysis
Natural Alternatives International
―
Sow Good
―
FitLife Brands
―
Bon Natural Life
―
Healthy Choice Wellness Corp. Class A
―
Ownership Overview
Options Prices
Currently, No data available
---